PAOG - Ohio manufacturer nears deal for extraction technology
April 28 2021 - 2:27PM
InvestorsHub NewsWire
April 28, 2021 -- InvestorsHub NewsWire -- via By James
Hale - MJBizDaily
![](https://mjbizdaily.com/wp-content/uploads/2021/04/MJBiz_Daily_logo_web.png)
The Ohio-based PAO Group (PAOG)
is one step closer to moving RespRX to market for the treatment of
chronic obstructive pulmonary disease (COPD).
PAOG, which acquired RespRX from Kali-Extracts in July, 2020,
has entered the final stage of negotiations to obtain 25 percent of
the patented extraction technology that enables the drug’s formula.
The agreement has the potential to lead to PAOG owning the patent
outright.
A leading cause of death, COPD—believed to affect some 16
million Americans—is an umbrella term used to describe progressive
lung diseases including emphysema, chronic bronchitis and
refractory (non-reversible) asthma.
A publicly traded company that provides pain management, massage
therapy, nutritional counseling, and hormone replacement, PAOG
plans to conduct a CBD in vivo histological research
study, a critical step in gaining regulatory approval for RespRX.
Funding for the study has also been secured.
Since acquiring RespRX, PAOG has been working with contract
research organization Veristat to validate and supplement the
research behind the drug, and in December announced a deal to
further study the effects of RespRX on COPD in league with the
Puerto Rico Consortium for Clinical Investigation.
Source - https://mjbizdaily.com/ohio-manufacturer-nears-deal-for-extraction-technology/
Other stocks on the move include
IGEX,
GVSI and
GGII
SOURCE: By James
Hale - MJBizDaily
Indo Global Exchanges Pte (PK) (USOTC:IGEX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Indo Global Exchanges Pte (PK) (USOTC:IGEX)
Historical Stock Chart
From Aug 2023 to Aug 2024